October 18, 2024
Retinopathy Articles
October 1, 2024
Ocular Side Effects of Systemic Chemotherapy Agents
By Kapil Mishra, MD, Rolando Sceptre Ganasi, BS
October 1, 2024
An Expanded Role for Faricimab?
By Lauren Pickel, BS, Nirojini Sivachandran, MD, PhD, FRCSC
October 1, 2024
Ocular Side Effects of Systemic Chemotherapy Agents
By Kapil Mishra, MD, Rolando Sceptre Ganasi, BS
October 1, 2024
An Expanded Role for Faricimab?
By Lauren Pickel, BS, Nirojini Sivachandran, MD, PhD, FRCSC
July 10, 2024
Cardiovascular Health Linked to Lower Retinopathy Risk in US Adults
July 1, 2024
Combined Phacovitrectomy Surgery
By Hiram J. Jimenez Davila, MD, Victor M. Villegas, MD, Timothy G. Murray, MD, MBA, FACS
July 1, 2024
A Roundtable on Complications in Retinal Surgery
By Christina Y. Weng, MD, MBA, Lejla Vajzovic, MD, FASRS, Yoshihiro Yonekawa, MD, et al.
July 1, 2024
Blue-light IOLs Reduce Progression of Macular Atrophy, But Not Incidence
By Rochelle Nataloni, contributing writer
July 1, 2024
Ocular Telehealth Program Enables Remote Retina Disease Screening
By Rochelle Nataloni, contributing writer
April 1, 2024
Upfront: Innovations in VEGF Inhibition Delivery
By Peter K. Kaiser, MD
April 1, 2024
Subspecialty News April 2024
By Rochelle Nataloni, contributing writer
April 1, 2024
Tyrosine Kinase Inhibitors for Wet AMD and Diabetic Retinopathy
By Nikhil Das, MD, Katherine E. Talcott, MD
April 1, 2024
Gene Therapy for Wet Age-related Macular Degeneration
By Khiem Sy Nguyen, BS, Samaantar Joshi, BS, Karen M. Wai, MD, et al.
March 1, 2024
Clinical Trial Update March 2024
March 1, 2024
Cost Effectiveness of Early Detection of Wet Age-related Macular Degeneration
By Samaantar Joshi, BS, Khiem Sy Nguyen, BS, Karen M. Wai, MD, et al.
March 1, 2024
Considerations in Management of Dry AMD
By Karen W. Jeng-Miller, MD, MPH
March 1, 2024
Upfront: An Ounce of Prevention
By Peter K. Kaiser, MD
March 1, 2024
Neovascularization in Macular Telangiectasia
By Zack Oakey, MD
January 1, 2024
Show Daily Coverage From the American Academy of Ophthalmology 2023 Annual Meeting
By Steve Lenier
January 1, 2024
Clinical Trial Update January/February 2024
November 1, 2023
Vitreoretinal Adverse Effects Associated With Oxymetazoline Drops for Blepharoptosis
By Jessica L. Barest, MD, Alan R. Dayan, MD
October 1, 2023
Effects of COVID-19 Infection and Vaccination in the Retina
By Fritz Gerald P. Kalaw, MD, William R. Freeman, MD
October 1, 2023
Neurotrophic Keratitis in Diabetic Patients Following Retinal Surgery
By Eric A. Lovett Jr., BS, MBA, Matthew R. Starr, MD, AJAY E. KURIYAN, MD, MS
October 1, 2023
SUBSPECIALTY NEWS: Biosimilar FDA application hits roadblock, Apellis provides guidance on Syfovre use, and more.
By Rochelle Nataloni, contributing writer
October 1, 2023
CLINICAL TRIAL DOWNLOAD: Twelve-month Data From a Phase 1 Clinical Trial of OTX-TKI for Wet AMD
By Arshad M. Khanani, MD, MA, FASRS, Paula Pecen, MD, Rabia Gurses Ozden, MD
October 1, 2023
Clinical Trial Update October 2023
October 1, 2023
Clinical Pearls for Newly Approved Treatments for GA
By Aamir A. Aziz, BS, Carl Danzig, MD
September 1, 2023
Bispecific Antibodies in Retina Therapies
By René Rückert, MD, MBA, Gemmy Cheung Chui Ming, FRCOphth, Marion R. Munk, MD, PhD, FEBO
September 1, 2023
UPFRONT: Medicine Evolves
By Peter K. Kaiser, MD
September 1, 2023
SUBSPECIALTY NEWS: Izervay FDA approval, ReST committee updates on Syfovre, and more.
By Rochelle Nataloni, contributing writer
September 1, 2023
Clinical Trial Update September 2023
July 1, 2023
SUBSPECIALTY NEWS: Mydriasis spray approved, laser and imaging devices cleared, new AI technology, and more.
By Rochelle Nataloni, contributing writer
June 1, 2023
The Current State of Treatment for Radiation Retinopathy
By Jonathan C. Tsui, MD, Apoorv P. Chebolu, MD, Brian L. Vanderbeek MD, MPH, MSCE
June 1, 2023
A Simple Guide for Treating Retinoblastoma
By Vishal R. Raval, MD, Stacey G. Zahler, DO, MS, Arun D. Singh, MD
June 1, 2023
SUBSPECIALTY NEWS: New product launches in laser and surgery, progress on clinical trials in dry AMD, and more.
By Rochelle Nataloni, contributing writer
October 1, 2022
Clinical Trial Update October 2022
September 1, 2022
NEW PRODUCT APPLICATIONS: Wearable Device Enhances Sight for People With Central Vision Loss
By Karen Appold, contributing writer
August 1, 2022
SUBSPECIALTY NEWS: Data presented on THR-149 and THR-687 for DME, pegcetacoplan NDA submitted, AREDS2 benefit confirmed, and more.
By Rochelle Nataloni, contributing writer
August 1, 2022
Clinical Trial Update Special Edition 2022
July 1, 2022
Vitreoretinal Views on Vuity
By Suzanne Michalak, MD, Prithvi Mruthyunjaya, MD, MHS, Ehsan Rahimy, MD
July 1, 2022
Clinical Trial Update July/August 2022
June 1, 2022
Intravitreal Methotrexate for the Treatment and Prevention of Proliferative Vitreoretinopathy
By Priya Vakharia, MD
April 1, 2022
Interpretation of Roth-like Spots
By Diana Driscoll, OD, David Callanan, MD
January 1, 2022
SUBSPECIALTY NEWS: Real-world Iluvien data, advances to program for choroidal melanoma treatment, results for at-home OCT, and more.
By Rochelle Nataloni, contributing writer
October 1, 2013
Solar Retinopathy: Etiology, Diagnosis, and Treatment
Advertisement
Recommendations
Advertisement